MetaCap

Pliant Therapeutics Inc. Company Profile

NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5951-0.0249 (-4.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pliant Therapeutics at a glance

Pliant Therapeutics Inc. (NASDAQ: PLRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in South San Francisco, CA. Pliant Therapeutics is led by Dr. Bernard Jozef Coulie M.B.A., M.D., Ph.D. and employs about 49 people. The company's shares have traded publicly since 2020.

At a market capitalization of $36.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001746473, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Pliant Therapeutics do?

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Business description based on the company's public filings.

Company information

Legal name
Pliant Therapeutics Inc.
Ticker
NASDAQ: PLRX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Bernard Jozef Coulie M.B.A., M.D., Ph.D.
Employees
49
Headquarters
331 Oyster Point Boulevard, South San Francisco, CA, United States
Phone
650 481 6770
IPO year
2020
Market cap
$36.89M
SEC CIK
0001746473
Latest annual report
10-K · Mar 11, 2026

Companies similar to Pliant Therapeutics

PLRX peer companies
CompanyPrice% ChgMarket capCompare
SDEVStablecoin Development Corporation0.50-10.30%$36.90Mvs PLRX
GRCEGrace Therapeutics Inc.1.71-0.58%$35.97Mvs PLRX
CNTBConnect Biopharma Holdings Limited0.59-6.08%$38.05Mvs PLRX
CUECue Biopharma Inc.4.15-7.78%$34.69Mvs PLRX
DWTXDogwood Therapeutics Inc.1.04-2.36%$39.57Mvs PLRX
VERUVeru Inc.1.94-8.06%$33.08Mvs PLRX
ATNMActinium Pharmaceuticals Inc. (Delaware)1.05-1.87%$33.01Mvs PLRX
TLPHTalphera Inc.0.7852+6.25%$40.80Mvs PLRX

Related